Victoria Baltrus Sells 958 Shares of Oscar Health (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) CAO Victoria Baltrus sold 958 shares of the business’s stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total transaction of $30,129.10. Following the completion of the sale, the chief accounting officer owned 213,631 shares in the company, valued at approximately $6,718,694.95. This trade represents a 0.45% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Trading Up 2.0%

Shares of NYSE:OSCR traded up $0.65 during trading on Tuesday, reaching $32.90. The company’s stock had a trading volume of 4,754,860 shares, compared to its average volume of 7,062,275. The stock has a market capitalization of $10.15 billion, a PE ratio of 23.50, a price-to-earnings-growth ratio of 0.66 and a beta of 2.37. Oscar Health, Inc. has a 12 month low of $10.69 and a 12 month high of $33.55. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.21. The firm’s 50 day simple moving average is $30.49 and its two-hundred day simple moving average is $22.87.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings data on Thursday, August 6th. The company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.70. The company had revenue of $4.88 billion for the quarter, compared to analysts’ expectations of $4.73 billion. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%.The firm’s revenue for the quarter was up 70.4% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.89) earnings per share. On average, research analysts predict that Oscar Health, Inc. will post 1.54 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. The Goldman Sachs Group restated a “neutral” rating and issued a $30.00 price target on shares of Oscar Health in a research report on Tuesday, August 11th. Wall Street Zen upgraded shares of Oscar Health from a “buy” rating to a “strong-buy” rating in a research report on Sunday, June 14th. UBS Group increased their target price on shares of Oscar Health from $20.00 to $26.00 and gave the company a “neutral” rating in a research note on Friday, August 7th. Robert W. Baird set a $27.00 target price on shares of Oscar Health in a report on Friday, August 7th. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $36.00 price target on shares of Oscar Health in a research note on Tuesday, July 28th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and eight have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $26.22.

Institutional Investors Weigh In On Oscar Health

A number of institutional investors and hedge funds have recently modified their holdings of the business. Nykredit A S purchased a new position in Oscar Health during the 2nd quarter valued at $130,000. California State Teachers Retirement System increased its stake in Oscar Health by 3,214.2% in the second quarter. California State Teachers Retirement System now owns 7,803,043 shares of the company’s stock worth $222,543,000 after purchasing an additional 7,567,600 shares during the period. Comprehensive Financial Planning Inc. PA bought a new stake in shares of Oscar Health during the second quarter worth $309,000. AXQ Capital LP bought a new stake in shares of Oscar Health during the second quarter worth $1,059,000. Finally, Wellington Management Group LLP boosted its stake in shares of Oscar Health by 65.6% during the second quarter. Wellington Management Group LLP now owns 603,675 shares of the company’s stock valued at $17,217,000 after purchasing an additional 239,109 shares during the period. 75.70% of the stock is owned by institutional investors.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.